Halia Therapeutics
PrivateLast Round
Seed Round
Aug 17, 2026
Total Funding Raised
$41.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Halia Therapeutics operates in Healthcare & Life Sciences and is based in Lehi, Utah. Its latest recorded funding round was a Grant round in March 2025.
Halia Therapeutics is a biopharmaceutical company that develops novel therapies targeting inflammasome-driven disease biology to treat inflammatory disorders and neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Halia Therapeutics Comparables
Compare Halia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NodThera | 90% | |
| Inflammasome Therapeutics | 86% | |
| Ventus Therapeutics | 84% |
For institutional investors. Book with your work email.
Halia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 17, 2026 | ||||
| Early Funding | Jul 1, 2025 | ||||
| Grant | Mar 11, 2025 | ||||
| Series C | Jan 31, 2024 | ||||
| Early Funding | Dec 16, 2022 | ||||
Series B | Feb 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2026
Raised $3.5M in a seed round.
- Jun 17, 2026
Monthly visitors grew 183% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
Halia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Halia Therapeutics's valuation, stock price, and market status.
Is Halia Therapeutics a public or private company?
Halia Therapeutics is a private company.
What is the current stock price of Halia Therapeutics?
Halia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Halia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Halia Therapeutics worth (valuation)?
Valuation information for Halia Therapeutics is not publicly available.
Can I buy Halia Therapeutics stock?
Halia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Halia Therapeutics's last funding round?
Halia Therapeutics's most recent funding round was Seed Round on August 17, 2026.
Who are the main investors in Halia Therapeutics?
Investor information for Halia Therapeutics is not publicly disclosed.
Will Halia Therapeutics IPO soon?
No public IPO plans have been announced for Halia Therapeutics.
How can I track Halia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Halia Therapeutics's shares on secondary markets.